ALPA LABORATORIES
|
ALPA LABORATORIES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 7.13 | 9.27 | 7.97 | 5.98 | 6.70 |
| CEPS(Rs) | 8.13 | 10.32 | 8.90 | 6.61 | 7.48 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 88.53 | 81.81 | 72.20 | 63.96 | 57.86 |
| Tax Rate(%) | 10.11 | 24.01 | 18.88 | 20.81 | 27.96 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 3.11 | 4.23 | 7.45 | 8.69 | 9.50 |
| EBIT Margin(%) | 16.02 | 23.03 | 19.35 | 17.34 | 17.62 |
| Pre Tax Margin(%) | 15.78 | 22.82 | 19.02 | 17.09 | 17.42 |
| PAT Margin (%) | 14.19 | 17.34 | 15.43 | 13.54 | 12.55 |
| Cash Profit Margin (%) | 16.16 | 19.30 | 17.23 | 14.97 | 14.03 |
| Performance Ratios | |||||
| ROA(%) | 6.45 | 9.61 | 9.60 | 7.80 | 9.53 |
| ROE(%) | 8.38 | 12.04 | 11.71 | 9.82 | 12.29 |
| ROCE(%) | 9.39 | 15.73 | 14.31 | 12.19 | 16.81 |
| Asset Turnover(x) | 0.45 | 0.55 | 0.62 | 0.58 | 0.76 |
| Sales/Fixed Asset(x) | 2.05 | 2.47 | 2.97 | 2.74 | 3.45 |
| Working Capital/Sales(x) | 0.67 | 0.77 | 0.82 | 0.78 | 1.03 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.49 | 0.40 | 0.34 | 0.37 | 0.29 |
| Receivable days | 151.19 | 142.78 | 147.50 | 166.43 | 119.43 |
| Inventory Days | 53.42 | 50.81 | 44.15 | 55.18 | 52.06 |
| Payable days | 100.34 | 79.22 | 71.98 | 99.58 | 103.71 |
| Valuation Parameters | |||||
| PER(x) | 6.48 | 11.23 | 10.46 | 8.99 | 10.38 |
| PCE(x) | 5.69 | 10.09 | 9.37 | 8.13 | 9.29 |
| Price/Book(x) | 0.52 | 1.27 | 1.16 | 0.84 | 1.20 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 0.92 | 1.93 | 1.65 | 1.15 | 1.34 |
| EV/Core EBITDA(x) | 5.09 | 7.72 | 7.79 | 6.11 | 7.02 |
| EV/EBIT(x) | 5.72 | 8.37 | 8.51 | 6.62 | 7.61 |
| EV/CE(x) | 0.51 | 1.26 | 1.14 | 0.78 | 0.97 |
| M Cap / Sales | 0.92 | 1.95 | 1.61 | 1.22 | 1.30 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -5.91 | 3.41 | 16.98 | -17.20 | 15.08 |
| Core EBITDA Growth(%) | -32.22 | 22.20 | 31.83 | -18.63 | 77.27 |
| EBIT Growth(%) | -34.53 | 23.09 | 30.58 | -18.54 | 82.07 |
| PAT Growth(%) | -23.04 | 16.25 | 33.33 | -10.71 | 94.45 |
| EPS Growth(%) | -23.04 | 16.25 | 33.33 | -10.71 | 94.45 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | - | 0.03 | 0.02 | 0.05 |
| Current Ratio(x) | 4.01 | 4.12 | 5.74 | 5.03 | 4.79 |
| Quick Ratio(x) | 3.76 | 3.74 | 5.25 | 4.61 | 4.25 |
| Interest Cover(x) | 65.72 | 111.73 | 58.58 | 72.07 | 90.32 |
| Total Debt/Mcap(x) | 0.03 | - | 0.03 | 0.02 | 0.04 |
Compare Financial Ratios of peers of ALPA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALPA LABORATORIES | ₹118.1 Cr | -2.8% | -8.9% | -33.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,483.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,248.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,822.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹105,427.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,492.3 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
ALPA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALPA LABORATORIES | -2.8% |
-8.9% |
-33.4% |
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses
